Tower Research Capital LLC (Trc) Voyager Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,306 shares of VYGR stock, worth $12,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,306

Previous 10,953 78.95%

Holding current value

$12,844

Previous $86,000 84.88%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.77 - $9.27 $49,893 - $80,157	-8,647 Reduced 78.95%	2,306 $13,000
Q2 2024 Aug 13, 2024	BUY	$7.42 - $10.54 $78,162 - $111,028	10,534 Added 2514.08%	10,953 $86,000
Q1 2024 May 15, 2024	SELL	$7.15 - $10.84 $42,757 - $64,823	-5,980 Reduced 93.45%	419 $3,000
Q4 2023 Feb 13, 2024	BUY	$6.28 - $8.81 $30,200 - $42,367	4,809 Added 302.45%	6,399 $54,000
Q3 2023 Nov 14, 2023	SELL	$7.55 - $11.25 $2,529 - $3,768	-335 Reduced 17.4%	1,590 $12,000
Q2 2023 Aug 14, 2023	BUY	$6.94 - $13.99 $8,168 - $16,466	1,177 Added 157.35%	1,925 $22,000
Q1 2023 May 09, 2023	SELL	$6.0 - $10.78 $34,488 - $61,963	-5,748 Reduced 88.49%	748 $6,000
Q4 2022 Feb 10, 2023	BUY	$4.94 - $6.61 $32,090 - $42,938	6,496 New	6,496 $40,000
Q2 2022 Aug 15, 2022	SELL	$4.82 - $10.09 $93,213 - $195,130	-19,339 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.75 - $9.44 $64,974 - $223,038	-23,627 Reduced 54.99%	19,339 $147,000
Q4 2021 Feb 14, 2022	BUY	$2.47 - $5.55 $74,687 - $167,820	30,238 Added 237.57%	42,966 $116,000
Q3 2021 Nov 15, 2021	BUY	$2.63 - $4.12 $18,357 - $28,757	6,980 Added 121.43%	12,728 $34,000
Q2 2021 Aug 16, 2021	BUY	$3.94 - $5.44 $4,460 - $6,158	1,132 Added 24.52%	5,748 $24,000
Q1 2021 May 17, 2021	BUY	$4.61 - $9.04 $15,060 - $29,533	3,267 Added 242.18%	4,616 $21,000
Q4 2020 Feb 16, 2021	SELL	$7.15 - $12.28 $54,861 - $94,224	-7,673 Reduced 85.05%	1,349 $10,000
Q3 2020 Nov 16, 2020	BUY	$10.01 - $13.75 $48,758 - $66,976	4,871 Added 117.35%	9,022 $96,000
Q2 2020 Aug 13, 2020	BUY	$8.05 - $14.21 $33,415 - $58,985	4,151 New	4,151 $52,000
Q4 2019 Feb 07, 2020	SELL	$12.82 - $16.85 $6,909 - $9,082	-539 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$16.31 - $28.29 $8,791 - $15,248	539 New	539 $9,000
Q2 2019 Aug 13, 2019	SELL	$19.18 - $27.88 $149,124 - $216,767	-7,775 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$8.0 - $19.66 $49,800 - $122,383	6,225 Added 401.61%	7,775 $149,000
Q4 2018 Feb 14, 2019	BUY	$8.59 - $18.05 $13,314 - $27,977	1,550 New	1,550 $15,000
Q3 2018 Nov 13, 2018	SELL	$17.11 - $21.74 $2,583 - $3,282	-151 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$16.76 - $23.92 $2,530 - $3,611	151 New	151 $3,000
Q1 2018 May 15, 2018	SELL	$16.16 - $31.31 $8,629 - $16,719	-534 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$12.26 - $25.88 $22,178 - $46,816	-1,809 Reduced 77.21%	534 $9,000
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $19,610 - $48,242	2,343	2,343 $48,000

Others Institutions Holding VYGR

# of Institutions

131

Shares Held

34.9M

Call Options Held

39.7K

Put Options Held

34.6K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $215M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Voyager Therapeutics, Inc. Transaction History